A Potential Use of Vidarabine: Alleviation of Functional Constipation Through Modulation of the Adenosine A2A Receptor-MLC Signaling Pathway and the Gut Microbiota
International Journal of Molecular Sciences · 2024
DOI: 10.3390/ijms252312810 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2024. Verfasst von Xiaoyu Gao und 7 weiteren Autor:innen. Beteiligte Einrichtung: Yunnan Key Laboratory of Precision Nutrition and Personalized Food Manufacturing, Yunnan Agricultural University, Kunming 650201, China. Hauptthemen laut MEDLINE: Constipation, Gastrointestinal Microbiome, Receptor, Adenosine A2A, Signal Transduction. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 85 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Xingdian talent plan of Yunnan Province, Yunnan Fundamental Research Projects, Yunnan Province-City Integration Project.
Abstract (Originalsprache)
Vidarabine (VID) is an antiviral medication that is commonly utilized to treat conditions such as hand, foot, and mouth disease and herpes. Constipation is a prevalent complication of these diseases. Could VID treat these diseases by influencing defecation behavior? To date, no studies have been conducted on the potential of VID to relieve constipation. Therefore, a systematic investigation was conducted into the laxative effects and mechanisms of VID using loperamide-induced functional constipated mice. The findings indicate that the oral administration of VID promoted gastrointestinal peristalsis, improved fecal properties, facilitated defecation, and demonstrated a significant laxative effect on functional constipated mice. It has been demonstrated that VID may increase the water content of feces by regulating the expression of aquaporins (AQP3, AQP4, and AQP8) in the colon and promote intestinal motility by regulating the expression of neurotransmitters (AChE and VIP) and the adenosine A2A receptor–myosin light chain (A2AR-MLC) signaling pathway in constipated mice. Concurrently, VID may also reduce colonic inflammation in constipated mice, reinforce the gut barrier function, and alter the composition and structure of the gut microbial community. Some microbial taxa, including Firmicutes and Lactobacillus, were found to be associated with the alleviation of constipation, while other taxa, including Bacteroidetes, Proteobacteria, Muribaculaceae, Muribaculum, norank__f__Desulfovibrionaceae, and Parasutterella, were found to be associated with constipation. These results indicate that the gut microbiota may play a significant role in the alleviation of constipation by VID. These findings confirm the efficacy of VID in a constipated animal model, which justifies further investigation into its potential clinical applications.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Yunnan Key Laboratory of Precision Nutrition and Personalized Food Manufacturing, Yunnan Agricultural University, Kunming 650201, China.
- College of Food Science and Technology, Yunnan Agricultural University, Kunming 650201, China.
- Engineering Research Center of Development and Utilization of Food and Drug Homologous Resources, Ministry of Education, Yunnan Agricultural University, Kunming 650201, China.
- Division of Science and Technology, Yunnan Agricultural University, Kunming 650201, China.
ORCID-Profile: Xiaoyu Gao
Förderung
- Xingdian talent plan of Yunnan Province
- Yunnan Fundamental Research Projects
- Yunnan Province-City Integration Project
- Scientific research fund of Yunnan provincial department of education
- Yunnan Province–City Integration Project
Zitieren
APA
Gao, X., Guo, K., Liu, S., Yang, W., Sheng, J., Tian, Y., Peng, L., & Zhao, Y. (2024). A Potential Use of Vidarabine: Alleviation of Functional Constipation Through Modulation of the Adenosine A2A Receptor-MLC Signaling Pathway and the Gut Microbiota. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms252312810
Vancouver
Gao X, Guo K, Liu S, Yang W, Sheng J, Tian Y, et al. A Potential Use of Vidarabine: Alleviation of Functional Constipation Through Modulation of the Adenosine A2A Receptor-MLC Signaling Pathway and the Gut Microbiota. International Journal of Molecular Sciences. 2024. doi:10.3390/ijms252312810
BibTeX
@article{Gao2024,
author = {Gao, Xiaoyu and Guo, Kaifeng and Liu, Shuangfeng and Yang, Weixing and Sheng, Jun and Tian, Yang and Peng, Lei and Zhao, Yan},
title = {A Potential Use of Vidarabine: Alleviation of Functional Constipation Through Modulation of the Adenosine A2A Receptor-MLC Signaling Pathway and the Gut Microbiota},
journal = {International Journal of Molecular Sciences},
year = {2024},
doi = {10.3390/ijms252312810}
}
EUVIMED